Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Fowler FJ Jr, Barry MJ, Walker-Corkery B, Caubet JF, Bates DW, Lee JM, Hauser A, McNaughton-Collins M.

J Gen Intern Med. 2006 Jul;21(7):715-21.

2.

Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result.

McNaughton-Collins M, Fowler FJ Jr, Caubet JF, Bates DW, Lee JM, Hauser A, Barry MJ.

Am J Med. 2004 Nov 15;117(10):719-25.

PMID:
15541320
3.

Prevalence of prostate specific antigen testing for prostate cancer in elderly men.

Dyche DJ, Ness J, West M, Allareddy V, Konety BR.

J Urol. 2006 Jun;175(6):2078-82.

PMID:
16697807
4.

[Advantages and risks of the use of prostate-specific antigen (PSA) in the health-care area No. 4 of Gijon (Asturias)].

Cepeda Piorno J, Rivas del Fresno M, Fuente Martín E, González García E, Muruamendiaraz Fernández V, Fernández Rodríguez E.

Arch Esp Urol. 2005 Jun;58(5):403-11. Spanish.

PMID:
16078781
5.

Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF, Crawford ED, Kramer BS, Andriole GL, Gelmann EP, Grubb R, Greenlee R, Gohagan JK.

BJU Int. 2007 Apr;99(4):775-9. Epub 2007 Jan 12.

6.

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, Lane JA, Peters TJ.

BJU Int. 2006 Oct;98(4):777-82.

7.

Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.

Kurahashi T, Miyake H, Shinozaki M, Oka N, Takenaka A, Hara I, Matsumura Y, Fujisawa M.

Int Urol Nephrol. 2008;40(2):345-9.

PMID:
17619159
8.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
9.

[Attitude of primary care physicians to early detection of prostatic cancer through prostate-specific antigen].

Oller Colom M, Jiménez Navarrete S, Hidalgo García A, Calvo Rosa E, Pérez Herrera MM, Castellanos Duarte RM, Simón Muela CI, Asens Mampel N, Duaso Allué I, Gascón Gazulla S.

Aten Primaria. 2000 Sep 30;26(5):323-6. Spanish.

PMID:
11100603
10.

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Freedland SJ, Sun L, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Moul JW, Aronson WJ.

BJU Int. 2008 Sep;102(8):969-74. doi: 10.1111/j.1464-410X.2008.07934.x. Epub 2008 Aug 7.

11.

The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.

Gosselaar C, Roobol MJ, Roemeling S, Schröder FH.

Eur Urol. 2008 Sep;54(3):581-8. doi: 10.1016/j.eururo.2008.03.104. Epub 2008 Apr 8.

PMID:
18423977
12.

Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.

Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA Jr.

J Clin Oncol. 2007 Jul 20;25(21):3076-81.

13.

Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.

Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A, Elwyn G, Cargill A, Austoker J.

Patient Educ Couns. 2006 Nov;63(3):367-79. Epub 2006 Jul 27.

PMID:
16875796
14.

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?

Macefield RC, Lane JA, Metcalfe C, Down L, Neal DE, Hamdy FC, Donovan JL.

Eur J Cancer. 2009 Sep;45(14):2569-73. doi: 10.1016/j.ejca.2009.03.016. Epub 2009 Apr 16.

PMID:
19375907
15.
16.

Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan.

Okihara K, Kitamura K, Okada K, Mikami K, Ukimura O, Miki T.

Int J Urol. 2008 Feb;15(2):156-60; discussion 161. doi: 10.1111/j.1442-2042.2007.01957.x.

17.

Behavioral associations between prostate and colon cancer screening.

Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ.

J Am Coll Surg. 2005 Feb;200(2):216-23.

PMID:
15664097
18.

Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.

Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB.

Eff Clin Pract. 2001 May-Jun;4(3):112-20.

PMID:
11434074
19.

Are prostatic biopsies necessary in men aged > or =80 years?

Bott SR, Foley CL, Bull MD, Reddy CC, Freeman A, Montgomery BS, Langley SE.

BJU Int. 2007 Feb;99(2):335-8.

PMID:
17326264
20.

The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.

Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, Magi-Galluzzi C.

BJU Int. 2007 Apr;99(4):770-4. Epub 2007 Jan 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk